Yuflyma
Product Images NDC 72606-063

Product Visual Gallery

This gallery contains 54 technical images submitted to the FDA as part of the official labeling for Yuflyma (NDC 72606-063). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Celltrion Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Yuflyma 01)

A line graph comparing the percentage of ACR20 responders over time (in weeks) between two groups: one receiving 40 mg every other week and a placebo group. The vertical axis shows percent ACR20 responders, and the horizontal axis shows time in weeks, with the 40 mg group consistently showing higher response rates than placebo over 48 weeks.*

FDA Label Image

Figure 2 (Yuflyma 02)

A line graph comparing the percentage of ASAS 20 response over 26 weeks between two groups: Adalimumab (N=208) and placebo (N=107). The graph shows response rate on the y-axis and time in weeks on the x-axis, illustrating a higher and sustained response with Adalimumab compared to placebo.*

FDA Label Image

Figure A (Yuflyma 03)

An instructional diagram showing a Yuflyma prefilled syringe before and after use. The 'Before Use' syringe illustration labels the cap, window displaying the medicine, and body. The 'After Use' syringe shows the needle cover with needle inside, stopper, plunger rod, and body.*

FDA Label Image

Figure B (Yuflyma 04)

An instructional diagram showing a testing device resembling a lateral flow test strip with a magnified view indicating where to locate the expiration date, formatted as month and year, on the device.*

FDA Label Image

Figure C (Yuflyma 05)

An instructional diagram showing a test device with a detailed close-up of the test window area. The device appears to be a narrow, elongated testing strip or cassette, with a rectangular result window highlighted in the magnified inset.*

FDA Label Image

Figure D (Yuflyma 06)

An instructional illustration for Yuflyma showing a clock indicating 15 to 30 minutes and an image of a white pen-like device. The clock illustration suggests a time interval related to the use of the device.*

FDA Label Image

Figure E (Yuflyma 07)

An illustration showing recommended injection sites for Yuflyma self-injection and caregiver administration. It highlights the abdomen around the navel and the front thighs as suitable injection areas on a human figure from the front view.*

FDA Label Image

Figure F (Yuflyma 08)

An illustration showing hands being washed under a running faucet with water flowing from the tap over the hands, indicating a handwashing or hygiene practice.*

FDA Label Image

Figure G (Yuflyma 09)

An instructional illustration showing a person cleaning their thigh skin with a wipe. The text 'clean your skin' is displayed to emphasize the cleaning step. The individual is seated, with one hand holding the wipe against the thigh area.*

FDA Label Image

Figure H (Yuflyma 10)

An instructional illustration showing the removal and safe disposal of the needle cover from a Yuflyma injection pen. The image depicts a hand pulling the needle cover upward from the pen and another hand dropping the cover into a disposal container, emphasizing safe needle handling and disposal.*

FDA Label Image

Figure I (Yuflyma 11)

An instructional illustration showing how to hold an injection device at a 90-degree angle to the skin for subcutaneous administration. Two positions are depicted: one with the device held vertically and the other horizontally against the abdomen area. The image includes annotations indicating the 90-degree injection angle for both positions.*

FDA Label Image

Figure J (Yuflyma 12)

Instructional diagram for Yuflyma injection showing the steps for administering the dose: start injection with first click, continue injection for 10 seconds after the second click, then count slowly to 5 seconds before end of injection, with corresponding hand and device illustrations.*

FDA Label Image

Figure K (Yuflyma 13)

An instructional illustration showing a hand pulling upward on a pen-like device labeled Yuflyma, with a zoomed-in view of a window indicator on the device, suggesting a step in its preparation or use process.*

FDA Label Image

Figure L (Yuflyma 14)

An instructional line drawing showing the lower part of a pen injector device with the needle cover labeled. The image focuses on identifying the needle cover component of the pen. No brand or dosage information is shown in the illustration.*

FDA Label Image

Figure M (Yuflyma 15)

An instructional illustration showing a hand holding a test device that appears to be placed into a waste container or receptacle. The test device visually resembles a strip or cassette with one or more test windows, featuring a green cap at the bottom.*

FDA Label Image

Figure A (Yuflyma 16)

An instructional diagram illustrating the components of a Yuflyma pre-filled syringe before and after use. Labels identify parts including the plunger, finger flange, viewing window, needle guard body, needle, and cap, demonstrating assembly and usage stages.*

FDA Label Image

Figure B (Yuflyma 17)

An instructional diagram of a Yuflyma prefilled syringe showing the location of the expiration date. The image highlights the syringe with a magnified view indicating where the expiration month and year are printed on the barrel.*

FDA Label Image

Figure C (Yuflyma 18)

An instructional diagram depicting a device with a plunger and a clear body, possibly a syringe or injector. The image includes a magnified circular inset highlighting a narrow, pointed internal structure within the device. This illustration appears to emphasize the internal tip design of the product.*

FDA Label Image

Figure D (Yuflyma 19)

An instructional illustration showing a syringe with a green handle and plunger against a gray background. Above the syringe, a clock face indicates a time range of 15 to 30 minutes, highlighting this duration with a shaded segment on the clock.*

FDA Label Image

Figure E (Yuflyma 20)

An illustration showing a human front torso and upper legs with four areas shaded in blue, indicating recommended sites for self-injection or caregiver injection. The shaded areas include the abdomen and the front of both thighs, with a legend confirming the blue color represents self-injection and caregiver administration sites for the product Yuflyma.*

FDA Label Image

Figure F (Yuflyma 21)

An illustration showing hands being held under a running faucet with water flowing, demonstrating hand washing or rinsing.*

FDA Label Image

Figure G (Yuflyma 22)

An instructional illustration showing a person cleaning their skin by wiping a cloth on the thigh. The text "clean your skin" appears on the left side of the image. No product packaging or drug information is visible.*

FDA Label Image

Figure H (Yuflyma 23)

Instructional diagram showing how to separate the cap from the syringe of Yuflyma, a product by CELLTRION USA, Inc. The image includes hand positions with arrows indicating the cap removal direction and an inset showing disposal of the cap into a container.*

FDA Label Image

Figure I (Yuflyma 24)

An instructional diagram showing two methods for subcutaneous injection at a 45-degree angle. The top panel depicts the needle being inserted into an area where the skin is pinched, and the bottom panel shows injection with the skin flat. A close-up of pinching the skin is shown in an inset circle.*

FDA Label Image

Figure J (Yuflyma 25)

An instructional illustration showing a hand holding a syringe with a safety guard, positioned at an angle against the skin of an arm. An arrow points downward indicating the direction of injection or placement of the syringe during administration, likely demonstrating how to properly inject Yuflyma.*

FDA Label Image

Figure K (Yuflyma 26)

An instructional illustration showing a hand holding a prefilled syringe with a green safety shield, positioned for an injection. The syringe is pointed towards a bent knee, with an arrow indicating the injection direction away from the skin.*

FDA Label Image

Figure L (Yuflyma 27)

An illustration showing a hand holding a syringe partially inserted into a sharps disposal container. The image depicts proper syringe disposal technique, highlighting a secure grip and placement of the syringe into the designated container.*

FDA Label Image

Figure A (Yuflyma 28)

An instructional diagram showing the parts of a prefilled syringe labeled as plunger, finger flange, body, medicine, needle, and cap. The diagram contrasts the syringe state before use, with the cap on and medicine inside, and after use, with the cap removed and medicine delivered.*

FDA Label Image

Figure B (Yuflyma 29)

An instructional illustration showing a prefilled syringe with a magnified detail highlighting the location of the expiration date, labeled as EXP: MONTH YEAR. The image pertains to the Yuflyma product by CELLTRION USA, Inc.*

FDA Label Image

Figure C (Yuflyma 30)

An instructional diagram showing a prefilled syringe with a close-up inset highlighting a portion near the syringe tip, likely illustrating proper assembly or injection technique. The image is associated with Yuflyma, a product by CELLTRION USA, Inc.*

FDA Label Image

Figure D (Yuflyma 31)

An illustration showing a syringe-type device with a plunger. Above it is a clock face indicating the time between 15 and 30 minutes, suggesting a waiting period or time interval related to the device usage.*

FDA Label Image

Figure E (Yuflyma 32)

Illustration showing recommended self-injection and caregiver injection sites on the human body for Yuflyma. Blue shaded areas indicate the abdomen and the front upper thighs as suitable injection locations for both self-injection and caregiver administration.*

FDA Label Image

Figure F (Yuflyma 33)

An illustration showing hands being washed under a running faucet, with water flowing from a tap over the hands positioned in a sink basin.*

FDA Label Image

Figure G (Yuflyma 34)

An instructional illustration showing a person seated, cleaning their skin on the thigh using a wipe or cloth. The text "clean your skin" is displayed to indicate a step in a preparation or application process.*

FDA Label Image

Figure H (Yuflyma 35)

An instructional illustration showing a hand holding a syringe with a protective cap being removed. An inset circle below depicts the proper disposal of the cap into a sharps container, emphasizing safe handling and disposal practices.*

FDA Label Image

Figure I (Yuflyma 36)

An instructional diagram showing two methods of subcutaneous injection at a 45-degree angle. The upper illustration depicts an injection into the forearm with a hand pinching the skin, while the lower illustration shows an injection into the abdomen with the skin pinched. Each uses a syringe with a blue plunger. A bold black bar separates the two scenes with the word 'OR' indicating choice between them.*

FDA Label Image

Figure J (Yuflyma 37)

An instructional illustration showing a hand administering an injection using a syringe into an upper arm. The syringe is being inserted at an angle, indicated by a black arrow pointing downwards toward the skin.*

FDA Label Image

Figure K (Yuflyma 38)

Illustration showing a hand holding a syringe positioned to inject at an upward angle into a patient's arm. The image demonstrates the proper injection technique for the Yuflyma medication by CELLTRION USA, Inc.*

FDA Label Image

Figure L (Yuflyma 39)

An instructional illustration depicting a hand placing a used syringe into a sharps disposal container. The image focuses on safe syringe disposal technique to prevent needle-stick injuries.*

FDA Label Image

Principal Display Panel (40 mg/0.4 mL Auto-injector Label)

Label for Yuflyma 40 mg/0.4 mL injection, containing adalimumab-aatty, for subcutaneous use. The label includes the NDC code 72606-030-09, the labeler CELLTRION USA, Inc., and a barcode. Space is reserved for pharmacode, lot number, and expiration date.*

FDA Label Image

40 mg/0.4 mL Auto-injector Carton 1pk (Yuflyma 41)

Packaging label for Yuflyma (adalimumab-aaty) injection, 40 mg/0.4 mL, a single-dose autoinjector. The label displays dosage form and strength, manufacturer CELLTRION USA, Inc., storage instructions, barcode, and directions for use. The design includes text emphasizing subcutaneous use only and safe handling guidance.*

FDA Label Image

40 mg/0.4 mL Auto-injector Carton 2pk (Yuflyma 42)

Packaging label for Yuflyma injection, containing adalimumab-aaty at 40 mg/0.4 mL strength. The single-dose autoinjector pack holds 2 autoinjectors. Labeler is CELLTRION USA, Inc., with storage and usage instructions included on the label, designed for subcutaneous use only.*

FDA Label Image

40 mg/0.4 mL Auto-injector Carton 4pk (Yuflyma 43)

Box packaging label for Yuflyma (adalimumab-aaaty) Injection 40 mg/0.4 mL by CELLTRION USA, Inc. It indicates a single-dose autoinjector with a package size of 4 autoinjectors. The label includes storage instructions, dosage recommendations, and a place to record autoinjector use dates. The label also notes it is for subcutaneous use only and prescription use.*

FDA Label Image

40 mg/0.4 mL Auto-injector Carton 6pk (Yuflyma 44)

Packaging label for Yuflyma (adalimumab-aabv) injection 40 mg/0.4 mL by CELLTRION USA, Inc. The label shows a carton design for six single-dose autoinjectors, with storage and usage instructions, dosage information, and a barcode.*

FDA Label Image

Principal Display Panel (40 mg/0.4 mL Syringe with safety guard Label)

Yuflyma 40 mg/0.4 mL injection label, displaying active ingredient adalimumab-aaty for subcutaneous use. The label includes lot and expiration date placeholders, NDC number 72606-030-05, and is marked Rx only. Manufactured by CELLTRION USA, Inc. A barcode and a pharmacopeia code section are also visible.*

FDA Label Image

40 mg/0.4 mL Syringe Carton (with Guard 1PK)

Packaging label for Yuflyma (adalimumab-aaty) injection, 40 mg/0.4 mL single-dose prefilled syringe with safety guard. Labeler is CELLTRION USA, Inc. The label includes dosage and storage instructions, barcode, and manufacturer information.*

FDA Label Image

40 mg/0.4 mL Syringe Carton (with Guard 2PK)

Packaging label for Yuflyma 40 mg/0.4 mL injection (adalimumab-aaty) by CELLTRION USA, Inc. The package contains 2 single-dose prefilled syringes with safety guard. The label includes administration instructions, storage conditions, and recommended dosage information, along with NDC 71606-030-06.*

FDA Label Image

40 mg/0.4 mL Syringe Carton (with Guard 4PK)

Packaging label for Yuflyma (adalimumab-aaty) injection, 40 mg/0.4 mL, by CELLTRION USA, Inc. The label includes dosage form as single-dose prefilled syringes with safety guard, quantity of 4 syringes per package, and storage instructions. It shows syringe illustrations and usage cautions, and includes labeler and lot information areas.*

FDA Label Image

40 mg/0.4 mL Syringe Carton (with Guard 6PK)

Packaging label for Yuflyma (adalimumab-aaty) Injection 40 mg/0.4 mL by CELLTRION USA, Inc. The label shows a six single-dose prefilled syringe carton with safety guard. Instructions and storage conditions are included, along with the NDC 71606-030-08.*

FDA Label Image

Principal Display Panel (40 mg/0.4 mL Syringe Label)

Yuflyma 40 mg/0.4 mL (adalimumab-aaty) injection label for subcutaneous use from CELLTRION USA, Inc. The label includes NDC 72606-030-01, lot and expiration date fields, and a barcode with a separate Pharmacoode section.*

FDA Label Image

40 mg/0.4 mL Syringe Carton 1pk (Yuflyma 51)

Packaging label for Yuflyma (adalimumab-aaty) Injection 40 mg/0.4 mL, single-dose prefilled syringe by CELLTRION USA, Inc. The label includes dosage instructions, storage conditions, ingredient list, and a syringe image. The product is designed for subcutaneous use only and contains one prefilled syringe per package.*

FDA Label Image

40 mg/0.4 mL Syringe Carton 2pk (Yuflyma 52)

Packaging label for Yuflyma (adalimumab-aalty) injection, 40 mg/0.4 mL single-dose prefilled syringes. The label displays two prefilled syringes per carton and includes dosage and storage instructions. Manufactured by CELLTRION USA, Inc., with NDC 71306-030-02, the label features the product name, strength, administration route, and handling guidelines.*

FDA Label Image

40 mg/0.4 mL Syringe Carton 4pk (Yuflyma 53)

Packaging label for Yuflyma injection (adalimumab-aaty) 40 mg/0.4 mL by CELLTRION USA, Inc. The label indicates four single-dose prefilled syringes. The label includes dosing information, storage instructions, and barcode details, with illustrations of the prefilled syringes. The product is intended for prescription use only.*

FDA Label Image

I40 mg/0.4 mL Syringe Carton 6pk (Yuflyma 54)

Packaging label for Yuflyma (adalimumab-aaty) injection, 40 mg/0.4 mL, single-dose prefilled syringes. The box contains 6 prefilled syringes and includes dosage and storage instructions. The labeler is CELLTRION USA, Inc. The layout shows fold lines and spaces for recording dates when syringes are removed from the refrigerator.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.